FDA Guidance on Digital Health Technologies in Clinical Trials
FDA Guidance on Digital Health Technologies in Clinical Trials Understanding FDA’s Expectations for Digital Health Tools in Trials Introduction: Digital Health and Regulatory Scrutiny As sponsors increasingly adopt digital health technologies (DHTs) like wearables, biosensors, and mobile apps in clinical trials, the U.S. Food and Drug Administration (FDA) has released specific guidance to help industry…
Read More “FDA Guidance on Digital Health Technologies in Clinical Trials” »